These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 3288869
21. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis. Champlin RE, Nimer SD, Oette D, Golde DW. Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137 [No Abstract] [Full Text] [Related]
22. Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defense. Gutterman J, Vadhan-Raj S, Logothetis C, Anaissle E, Estey E, Talpaz M, Kurzrock R. Semin Hematol; 1990 Jul; 27(3 Suppl 3):15-24. PubMed ID: 2198660 [Abstract] [Full Text] [Related]
23. In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromes. Hoelzer D, Ganser A, Völkers B, Greher J, Walther F. Blood Cells; 1988 Jul; 14(2-3):551-9. PubMed ID: 3067785 [Abstract] [Full Text] [Related]
24. The clinical use of hematopoietic growth factors. Appelbaum FR. Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905 [Abstract] [Full Text] [Related]
31. Rationals for the development of the human hematopoietic colony stimulating factors as therapeutical useful drugs. Krumwieh D, Schulz G, Seiler FR. Behring Inst Mitt; 1988 Apr; (82):265-81. PubMed ID: 2457362 [Abstract] [Full Text] [Related]
32. Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor. Lynch M, Yanes L, Todd K. Oncol Nurs Forum; 1988 Apr; 15(4):463-9. PubMed ID: 3041383 [No Abstract] [Full Text] [Related]
33. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates. Gillio AP, Bonilla MA, Potter GK, Gabrilove JL, O'Reilly RJ, Souza LM, Welte K. Transplant Proc; 1987 Dec; 19(6 Suppl 7):153-6. PubMed ID: 3321642 [No Abstract] [Full Text] [Related]
34. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. Peters WP, Kurtzberg J, Atwater S, Borowitz M, Rao M, Currie M, Gilbert C, Shpall EJ, Jones RB, Ross M. Prog Clin Biol Res; 1990 Dec; 338():121-8. PubMed ID: 2189135 [No Abstract] [Full Text] [Related]
37. [Expectations in the clinical application of human-recombinant cytokines. 4) Interleukin-3 and colony-stimulation factors]. Takaku F. Nihon Rinsho; 1988 May 15; 46(5):1105-11. PubMed ID: 2457722 [No Abstract] [Full Text] [Related]
38. Cost considerations in therapy with myeloid growth factors. Glaspy JA, Jakway J. Am J Hosp Pharm; 1993 Jul 15; 50(7 Suppl 3):S19-26. PubMed ID: 7689789 [Abstract] [Full Text] [Related]